Tryp Therapeutics Revenue

Biotechnology Research • Melbourne, Victoria, Australia • 1-10 Employees

Tryp Therapeutics revenue & valuation

Annual revenue	$769,995
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,500,000
Total funding	$6,300,000

Key Contact at Tryp Therapeutics

Daniel Tillett

Non Executive Director

Company overview

Headquarters	Suite 201, 697 Burke Road Camberwell, Melbourne, Victoria 3124, AU
Website	tryptherapeutics.com
NAICS	541714
Employees	1-10
Socials

Tryp Therapeutics Email Formats

Tryp Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@tryptherapeutics.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@tryptherapeutics.com	100%

About Tryp Therapeutics

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The Company has an ongoing Phase 2a clinical trial for the treatment of Binge Eating Disorder at the University of Florida and an upcoming Phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit has been demonstrated, subsequent studies are expected to utilize TRP-8803 which has the potential to further improve efficacy, safety and patient experience.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Entry

Employees by Department

Tryp Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Tryp Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-12-02	16	$2,100,000
2024-06-01	14	$4,200,000

Funding Insights

$6,300,000

Total funding amount

$4,200,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Tryp Therapeutics is located in Melbourne, Victoria, AU.

Tryp Therapeutics generates an estimated annual revenue of $769,995. This revenue figure reflects the company's market position and business performance in its industry.

Tryp Therapeutics has an estimated valuation of $2,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Tryp Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Tryp Therapeutics has raised a total of $6,300,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Tryp Therapeutics

Daniel Tillett

Non Executive Director

4.8

40,000 users